	Beneficio Bruto En Ventas		Fecha
Abbott	USD 6.54B	625M	2025-12
AtriCure	USD 105.34M	4M	2025-12
Avanos Medical	USD 86M	0	2025-12
Baxter International	USD 577M	373M	2025-12
Becton, Dickinson and Co.	USD 2.41B	1.72B	2025-12
Boston Scientific	USD 3.68B	136M	2025-12
CONMED	USD 218.29M	52.17M	2025-12
Cooper Companies	USD 650.8M	62.6M	2025-09
Danaher	USD 3.97B	443M	2025-12
Dexcom	USD 792.7M	61.3M	2025-12
Edwards Lifesciences	USD 1.23B	18.7M	2025-12
Globus Medical	USD 535.95M	49.28M	2025-12
Haemonetics	USD 202.39M	7.64M	2025-12
Hologic	USD 586.4M	2.9M	2025-12
Insulet	USD 568.6M	58.5M	2025-12
Integra LifeSciences	USD 217.1M	10.11M	2025-12
Intuitive Surgical	USD 1.9B	241.9M	2025-12
J&J	USD 16.6B	118M	2025-12
Masimo	USD 230.6M	2.7M	2025-09
Medtronic	USD 5.41B	27M	2025-12
Merit Medical Systems	USD 195.35M	8.94M	2025-12
Olympus	JPY 164.9B	3.6B	2025-12
Smith & Nephew	USD 2.09B	117M	2025-12
Steris	USD 655.5M	9.6M	2025-12
Stryker	USD 4.49B	633M	2025-12
Tandem Diabetes Care	USD 167.46M	33.17M	2025-12
Teleflex	USD 307.45M	144.2M	2025-12
Terumo	JPY 153.19B	6.2B	2025-12
Zimmer Biomet Holdings	USD 1.27B	8.1M	2025-12

Stryker Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.